Ilya Zubkov
Stock Analyst at Freedom Capital Markets
(2.38)
# 3,112
Out of 5,128 analysts
40
Total ratings
39.1%
Success rate
2.9%
Average return
Main Sectors:
Stocks Rated by Ilya Zubkov
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LGCY Legacy Education | Maintained: Buy | $13 | $8.30 | +56.63% | 1 | Nov 13, 2026 | |
| LFVN LifeVantage | Maintained: Buy | $8 | $5.18 | +54.44% | 1 | Nov 13, 2026 | |
| INMB INmune Bio | Maintained: Buy | $2.5 | $1.05 | +138.10% | 1 | Nov 13, 2026 | |
| INGN Inogen | Maintained: Buy | $12 → $9.5 | $6.12 | +55.36% | 2 | Nov 11, 2026 | |
| CLYM Climb Bio | Maintained: Buy | $26 | $11.76 | +121.09% | 1 | Nov 10, 2026 | |
| VMD Viemed Healthcare | Reiterated: Hold | $11 → $10 | $8.95 | +11.73% | 2 | Nov 9, 2026 | |
| AMGN Amgen | Downgraded: Hold | $375 → $470 | $465.23 | +1.03% | 2 | Nov 6, 2026 | |
| ATYR aTyr Pharma | Downgraded: Hold | $140 → $5 | $7.58 | -34.04% | 2 | Nov 6, 2026 | |
| NAGE Niagen Bioscience | Reiterated: Buy | $9 → $6 | $2.28 | +163.16% | 2 | Nov 6, 2026 | |
| PFE Pfizer | Reiterated: Buy | $34 | $29.23 | +16.32% | 1 | Nov 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $315 | $293.30 | +7.40% | 1 | Nov 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $185 → $200 | $220.78 | -9.41% | 2 | Nov 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $140 | $148.76 | -5.89% | 1 | Nov 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $350 | $156.61 | +123.49% | 1 | Oct 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1,600 | $1,411.95 | +13.32% | 1 | Oct 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $245 → $275 | $254.87 | +7.90% | 2 | Oct 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5 | $3.57 | +40.06% | 2 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $35 | $32.10 | +9.03% | 2 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $280 | $282.11 | -0.75% | 1 | Jul 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $27 | $9.49 | +184.51% | 1 | Jul 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $10 | $8.18 | +22.25% | 1 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $16 | $12.12 | +32.01% | 1 | Apr 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $116 | $86.94 | +33.43% | 1 | Apr 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $20 | $3.15 | +534.92% | 1 | Mar 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $6 | $1.86 | n/a | 1 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $14 → $37 | $17.24 | n/a | 2 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $11 | $4.36 | n/a | 1 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $13 | $9.49 | n/a | 1 | Jul 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $29 | $27.06 | n/a | 1 | Jul 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $2.10 | n/a | 1 | Mar 18, 2025 |
Legacy Education
Nov 13, 2026
Maintained: Buy
Price Target: $13
Current: $8.30
Upside: +56.63%
LifeVantage
Nov 13, 2026
Maintained: Buy
Price Target: $8
Current: $5.18
Upside: +54.44%
INmune Bio
Nov 13, 2026
Maintained: Buy
Price Target: $2.5
Current: $1.05
Upside: +138.10%
Inogen
Nov 11, 2026
Maintained: Buy
Price Target: $12 → $9.5
Current: $6.12
Upside: +55.36%
Climb Bio
Nov 10, 2026
Maintained: Buy
Price Target: $26
Current: $11.76
Upside: +121.09%
Viemed Healthcare
Nov 9, 2026
Reiterated: Hold
Price Target: $11 → $10
Current: $8.95
Upside: +11.73%
Amgen
Nov 6, 2026
Downgraded: Hold
Price Target: $375 → $470
Current: $465.23
Upside: +1.03%
aTyr Pharma
Nov 6, 2026
Downgraded: Hold
Price Target: $140 → $5
Current: $7.58
Upside: -34.04%
Niagen Bioscience
Nov 6, 2026
Reiterated: Buy
Price Target: $9 → $6
Current: $2.28
Upside: +163.16%
Pfizer
Nov 6, 2026
Reiterated: Buy
Price Target: $34
Current: $29.23
Upside: +16.32%
Nov 4, 2026
Reiterated: Buy
Price Target: $315
Current: $293.30
Upside: +7.40%
Nov 2, 2026
Reiterated: Hold
Price Target: $185 → $200
Current: $220.78
Upside: -9.41%
Nov 2, 2026
Reiterated: Hold
Price Target: $140
Current: $148.76
Upside: -5.89%
Oct 30, 2026
Reiterated: Buy
Price Target: $350
Current: $156.61
Upside: +123.49%
Oct 30, 2026
Reiterated: Buy
Price Target: $1,600
Current: $1,411.95
Upside: +13.32%
Oct 29, 2026
Reiterated: Buy
Price Target: $245 → $275
Current: $254.87
Upside: +7.90%
Aug 11, 2026
Reiterated: Hold
Price Target: $5
Current: $3.57
Upside: +40.06%
Aug 3, 2026
Downgraded: Hold
Price Target: $35
Current: $32.10
Upside: +9.03%
Jul 16, 2026
Upgraded: Buy
Price Target: $280
Current: $282.11
Upside: -0.75%
Jul 2, 2026
Initiated Coverage: Buy
Price Target: $27
Current: $9.49
Upside: +184.51%
May 18, 2026
Upgraded: Hold
Price Target: $10
Current: $8.18
Upside: +22.25%
Apr 6, 2026
Initiated Coverage: Buy
Price Target: $16
Current: $12.12
Upside: +32.01%
Apr 2, 2026
Initiated Coverage: Buy
Price Target: $116
Current: $86.94
Upside: +33.43%
Mar 30, 2026
Upgraded: Buy
Price Target: $20
Current: $3.15
Upside: +534.92%
Sep 30, 2025
Initiated Coverage: Buy
Price Target: $6
Current: $1.86
Upside: n/a
Aug 11, 2025
Upgraded: Buy
Price Target: $14 → $37
Current: $17.24
Upside: n/a
Aug 4, 2025
Initiated Coverage: Buy
Price Target: $11
Current: $4.36
Upside: n/a
Jul 14, 2025
Initiated Coverage: Buy
Price Target: $13
Current: $9.49
Upside: n/a
Jul 1, 2025
Initiated Coverage: Buy
Price Target: $29
Current: $27.06
Upside: n/a
Mar 18, 2025
Reiterated: Buy
Price Target: $13
Current: $2.10
Upside: n/a